Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–13 of 13 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT01219075
- Conditions
- Adenocarcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +20 more
- Locations
-
- University of Southern California Los Angeles, California, United States
NCT02314156
- Conditions
- Adenocarcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +20 more
- Locations
-
- Cedars-Sinai Medical Center West Hollywood, California, United States
- Northwestern University Chicago, Illinois, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT01540565
- Conditions
- Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +20 more
- Locations
-
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- John Muir Medical Center-Concord Campus Concord, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Gynecologic Oncology Associates-Newport Beach Newport Beach, California, United States
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy
NCT00892736
- Conditions
- Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +48 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
NCT00986206
- Conditions
- Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +19 more
- Locations
-
- Women and Infants Hospital of Rhode Island Providence, Rhode Island, United States
NCT01097278
- Conditions
- Adenocarcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +14 more
- Locations
-
- Northeast Alabama Regional Medical Center Anniston, Alabama, United States
- Providence Hospital Mobile, Alabama, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Regional Hospital Anchorage, Alaska, United States
NCT01874184
- Conditions
- Adenocarcinoma, Atypical Ductal Breast Hyperplasia, Atypical Lobular Breast Hyperplasia, +17 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01154426
- Conditions
- Adult Solid Neoplasm, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier
- Locations
-
- Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States
- UPMC-Magee Womens Hospital Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
NCT00535119
- Conditions
- Adnexal Diseases, Adult Solid Neoplasm, BRCA1 Mutation Carrier, +23 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
NCT00098800
- Conditions
- Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +19 more
- Locations
-
- Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian
NCT02208375
- Conditions
- Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +35 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
NCT01905046
- Conditions
- Adenocarcinoma, Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier, +16 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Los Angeles County-USC Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
NCT00080756
- Conditions
- BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Breast Cancer, +6 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States